2nd Annual MarketsandMarkets

Biomarker and Companion Diagnostics Conference - East Coast Edition

20th - 21st June 2024

Boston, USA

From Discovery to Diagnosis: Bridging the Biomarker Gap

MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA.

MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference:

Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge biomarker research and applications. Esteemed keynote speakers will deliver groundbreaking insights into the latest developments and future prospects of biomarker research, making it a hub for fostering collaboration and driving innovation. Anticipated as the largest industry-led meeting, this conference unites over 200 senior decision-makers in the biomarker and CDx field, providing unparalleled insights. Attendees will gain actionable insights to identify biomarker and CDx development advancements across oncology and non-oncology indications, including NASH, Alzheimer’s, and Parkinson’s, revolutionizing personalized medicine pipelines. The summit will address challenges in analytical validation, explore regulatory landscapes, and leverage bioinformatics and AI for enhanced biomarker discovery. The 2024 summit promises an exclusive opportunity for knowledge sharing and networking among industry leaders, making a marked difference in patient outcomes.

Tag Line
30+ experts from academia and industry will be presenting their current work in Biomarkers, Latest updates on regulatory guidelines and approvals, Cancer biomarker validation for clinical application, Biomarkers and Personalized Medicine, Impact of Big data in translational biomarker research and Future of Companion Diagnostics
Tag Line
Opportunity to develop long-lasting business relationships and networking opportunities with researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies, Universities, and Research institutes.
Tag Line
Over 20 presentations, round-tables, and panel discussions focused on the key opportunities and challenges in biomarker research, from precision medicine and companion diagnostics through to digital biomarkers and clinical trials.

MarketsandMarkets 7th Annual Next Gen Immuno-Oncology Conference:

Explore the forefront of cancer treatment at our flagship Immuno-Oncology Conference. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. With more than 40 speakers across the world from pharma, biopharma and biotech companies, the congress will discuss the latest updates and share insights in development of ADC’s, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy shaping the future of immuno-oncology.

Join us for this transformative event, where innovation meets collaboration, shaping the future of healthcare and biotechnology.

CO-LOCATED CONFERENCES

7th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference

WHAT TO EXPECT

  • Biomarker Discovery Techniques: Explore novel strategies, including genomics, proteomics, metabolomics, and bioinformatics, to identify cutting-edge biomarkers.
  • Precision Medicine Tailoring: Understand the pivotal role of biomarkers in customizing treatments for individual patients, enhancing efficacy, and minimizing side effects.
  • Rigorous Biomarker Validation: Learn strategies and overcome challenges in validating biomarkers for clinical use, ensuring robust and reliable results.
  • Clinical Applications Across Disorders: Delve into biomarker applications in cancer, immunology, neurodegenerative disorders, and cardiovascular conditions for targeted advancements.
  • Bioinformatics and AI Analysis: Attend workshops and sessions on biomarker data analysis, employing machine learning and artificial intelligence approaches for comprehensive insights.
  • Biomarker-Based Diagnostics Development: Gain insights into the development and commercialization of diagnostic tests and platforms based on biomarkers.
  • Regulatory Frameworks for CDx: Stay updated on current regulatory frameworks for CDx development, facilitating smoother approvals and applications.
  • Expanding Biomarker Testing Access: Navigate reimbursement landscapes through cross-sector collaborations to widen access to biomarker testing.
  • Innovative Strategies in CDx Development: Implement new CDx strategies to bring innovative therapies to the clinic, ensuring effective market access in line with global trends.
  • Collaboration for Advancement: Explore sessions on fostering collaboration among academia, industry, and government agencies to drive biomarker research forward.

  1. Cutting-Edge Insights: Access the latest advancements in biomarker discovery, precision medicine, and clinical applications spanning cancer, immunology, neurodegenerative disorders, and cardiovascular biomarkers.
  2. Innovative Immunotherapy: Dive into immune-oncology projects, exploring antibodies, cellular therapy, and immune checkpoint research. Contribute to interactive discussions, share your work, and stay updated on cutting-edge technologies and platforms.
  3. Networking and Collaboration: Connect with industry leaders, researchers, and peers. Foster collaborations, engage in thought-provoking discussions, and explore partnership opportunities.
  4. Professional Development: Enhance your skills with workshops on biomarker data analysis, machine learning, and artificial intelligence applications. Learn best practices and methodologies for biomarker and IO research.
  5. Practical Applications: Discover how research translates into real-world applications. Explore exhibitor showcases, demonstrations, and case studies, gaining insights into the latest tools and technologies.
  6. Personal and Industry Growth: Step out of your comfort zone, engage in interactive roundtables, and contribute to key discussions. Elevate your personal and professional growth within the dynamic fields of biomarker research and immunotherapy.

Engage in groundbreaking research, expand your network, and drive innovation at the Immunobio Series, where science meets collaboration.

Researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies & Universities and Research institutes working in:

  • Biomarker discovery/development
  • Translational research
  • Clinical Biomarker
  • Biomarkers in IO and Neurological disorders
  • Imaging Biomarkers
  • Pathology
  • Companion Diagnostics
  • Biomarker Imaging
  • Proteomics Biomarkers
  • Experimental Medicine
  • Data Science
  • Biomarkers in Clinical Discovery
  • Immuno-oncology/Neuroscience Drug Discovery
  • Diagnostic Biomarkers development
  • Personalized Medicine
  • Immunology Biomarkers

CONFERENCE AGENDA

Registration

08:15 - 08:50

Welcome note from MarketsandMarkets

08:50 - 08:55

Opening Remarks from the Chairperson

08:55 - 09:00

Keynote Presentation - Regulatory Framework for Biomarker Diagnostics: Insights and Strategies

09:00 - 09:30

Modeling Strategies for Biomarker-driven Drug Discovery: PK/PD, QSP, and MIDD

09:30 - 10:00

Reserved Slot for Gold Sponsor

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:30 - 11:15

Reserved Slot for Silver Sponsor

11:15 - 11:45

Advancing Digital Pathology in biomarker identification to revolutionize patient stratification

11:45 - 12:15

Facilitating Agile Global Drug Development with Precision Medicine-Driven Biomarker Deployment: Ensuring Harmonized Assays Across Varied Regional Regulations

Zheng Feng

Zheng Feng, Head, Molecular Biomarkers & Genomics, EMD Serono

12:15 - 12:45

Role of Biomarkers in Clinical Trials: Enhancing Patient Monitoring and Therapeutic Evaluation

12:45 - 13:15

Lunch and Poster Presentation | One-to-One Networking Meetings

13:15 - 14:15

Functional biomarker assay development for cancer treatment

14:15 - 14:45

Assessing the Safety and Efficacy of ctDNA in Augmenting Immunotherapy Interventions

14:45 - 15:15

Dissection of the Tumor Microenvironment Using Spatial Transcriptomics and Deep Learning

Mario Flores

Mario Flores, Assistant Professor, Department of Biomedical Engineering, The University of Texas at San Antonio

15:15 - 15:45

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meetings

15:45 - 16:30

Predictive Modeling in Biomarker Research: Harnessing AI and Informatics for Prognostic Signatures

16:30 - 17:00

Panel Discussion: Real world data for precision oncology based smart enrollment

17:00 - 17:30

Closing Remarks from the Chairperson

17:30 - 17:30

Registration

08:15 - 08:55

Opening Remarks from the Chairperson

08:55 - 09:00

Keynote Presentation (Reserved for Platinum Sponsor)

09:00 - 09:30

Reserved Slot for Gold Sponsor

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:30 - 11:15

Reserved Slot for Silver Sponsor

11:15 - 11:45

Lunch and Poster Presentation | One-to-One Networking Meetings

13:15 - 14:15

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meetings

15:45 - 16:30

Closing Remarks from the Chairperson

17:30 - 17:30

Registration

08:15 - 08:50

Welcome note from MarketsandMarkets

08:50 - 08:55

Opening Remarks from the Chairperson

08:55 - 09:00

Keynote Presentation - Navigating CDx Partnerships: Strategies and Considerations for Pharma Companies

09:00 - 09:30

From Assay Development to Commercialization: CDx Strategy in Genetics Medicine

Melis McHenry

Melis McHenry, Associate Director, Precision Medicine CDx, Regeneron

09:30 - 10:00

Solution Provider Presentation-Reserved for Gold Sponsor

10:00 - 09:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:30 - 11:15

Solution Provider Presentation-Reserved for Silver Sponsor

11:15 - 11:45

Maximizing Minimal Residual Disease (MRD) in Drug Development and Therapy Commercialization Strategies

11:45 - 12:45

Exploring International Regulatory and Commercial Considerations to shape the Future of Diagnostics

12:15 - 12:45

Global Commercialization and fast-tracked Market Access Strategies for Companion Diagnostics

12:45 - 13:15

Lunch and Poster Presentation | One-to-One Networking Meetings

13:15 - 14:15

Leveraging IO markers for companion diagnostics development

14:15 - 14:45

Innovative Safety Biomarker Applications to Drug Development

14:45 - 15:15

Advancements in Imaging Biomarkers for Neurodegenerative Diagnosis and Monitoring

15:15 - 15:45

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meetings

15:45 - 16:30

Panel Discussion: Opportunities and Challenges in Biomarker Testing: Comparing Oncology and Non-Oncology Perspectives

16:30 - 17:00

Closing Remarks from the Chairperson

17:00 - 17:00

Registration

08:15 - 08:55

Opening Remarks from the Chairperson

08:55 - 09:00

Keynote Presentation (Reserved for Platinum Sponsor)

09:00 - 09:30

Solution Provider Presentation (Reserved for Gold Sponsor)

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:30 - 11:15

Solution Provider Presentation (Reserved for Silver Sponsor)

11:15 - 11:45

Lunch and Poster Presentation | One-to-One Networking Meetings

13:15 - 14:15

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meetings

15:45 - 16:30

Closing Remarks from the Chairperson

17:00 - 17:00

SPEAKERS

Lindsay Darling

Lindsay Darling

Director, Companion Diagnostics Portfolio Management & Operations, Regeneron

Bhaskarjyoti Sarmah

Bhaskarjyoti Sarmah

Associate Scientific Director, Clinical Biomarkers, Moderna

Althea Lang

Althea Lang

Scientific Project Manager, Foundation for the National Institutes of Health

Amanda Acerbi

Amanda Acerbi

Precision Medicine Global Director, Janssen

Zheng Feng

Zheng Feng

Head, Molecular Biomarkers & Genomics, EMD Serono

Mario Flores

Mario Flores

Assistant Professor, Department of Biomedical Engineering, The University of Texas at San Antonio

Nirmit Kumar

Nirmit Kumar

Senior Global Medical Affairs Leader, Diagnostic Oncology, AstraZeneca

Cecilia Schott

Cecilia Schott

Vice President, Global Head Precision Diagnostics, Novartis AG

Melis McHenry

Melis McHenry

Associate Director, Precision Medicine CDx, Regeneron

Wenting Wang

Wenting Wang

Oncology Biomarker Statistics Team Lead, Sanofi

Ravinder Singh

Ravinder Singh

Professor of Laboratory Medicine and Pathology, Mayo Clinic

John Beeler

John Beeler

Business Development Search & Evaluation Lead - Innovative Technologies - Translational Medicine, Bristol Myers Squibb

ENQUIRE NOW

SPONSORS

LOCATION

Venue

Boston, USA

PAST EVENT GALLERY